BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 8769704)

  • 21. Mini-ICE regimen as mobilization therapy for chronic myelogenous leukaemia patients at diagnosis.
    Sureda A; Petit J; Brunet S; Boqué C; Aventín A; Martino R; González JR; Amill B; Larriba I; Blanco A; Martín-Henao GA; Sierra J; Grañena A
    Bone Marrow Transplant; 1999 Dec; 24(12):1285-90. PubMed ID: 10627636
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autografting in chronic myeloid leukemia.
    Carella AM; Beltrami G; Corsetti MT
    Semin Hematol; 2003 Jan; 40(1):72-8. PubMed ID: 12563613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A prospective study of alpha-interferon and autologous bone marrow transplantation in chronic myeloid leukemia. The Italian Co-operative Study Group on Chronic Myeloid Leukemia.
    Meloni G; Russo D; Baccarani M; Testoni N; Martinelli G; Fanin R; Zuffa E; Rosti G; Alimena G; Saglio G; Mandelli F; Tura S
    Haematologica; 1999 Aug; 84(8):707-15. PubMed ID: 10457406
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Autologous stem cell transplantation in chronic myeloid leukaemia using Philadelphia chromosome negative blood progenitors mobilised with hydroxyurea and G-CSF.
    Pratt G; Johnson RJ; Rawstron AC; Barnard DL; Morgan GJ; Smith GM
    Bone Marrow Transplant; 1998 Mar; 21(5):455-60. PubMed ID: 9535037
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Autologous hematopoietic cell transplantation for chronic myelogenous leukemia.
    Bhatia R; McGlave PB
    Hematol Oncol Clin North Am; 2004 Jun; 18(3):715-32, xi. PubMed ID: 15271402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F; Kirkland MA; van Rhee FV; Chase A; Coulthard S; Bungey J; Goldman JM; Cross NC
    Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
    Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Spontaneous graft-versus-host disease following autologous peripheral blood progenitor cell transplantation in chronic myeloid leukaemia.
    Rainey MG; Harrison P; Hows JM; Kingston PJ; Burton PA; Codling BW; Howell RT; Slade RR
    Bone Marrow Transplant; 1996 Jun; 17(6):1077-9. PubMed ID: 8807117
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Engraftment of HLA-matched sibling hematopoietic stem cells after immunosuppressive conditioning regimen in patients with hematologic neoplasias.
    Carella AM; Lerma E; Dejana A; Corsetti MT; Celesti L; Bruni R; Benvenuto F; Figari O; Parodi C; Carlier P; Florio G; Lercari G; Valbonesi M; Casarino L; De Stefano F; Geniram A; Venturino M; Tedeschi L; Palmieri G; Piaggio G; Podestà M; Frassoni F; Van Lint MT; Marmont AM; Bacigalupo A
    Haematologica; 1998 Oct; 83(10):904-9. PubMed ID: 9830799
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eradication of the Philadelphia chromosome-positive clone and persistent restoration of normal polyclonal haemopoiesis in a chronic myelogenous leukemia patient after autologous transplant with peripheral blood Philadelphia-negative haemopoietic cells.
    Carella AM; Frassoni F; Podesta M; Saglio G
    Bone Marrow Transplant; 1994 May; 13(5):668-9. PubMed ID: 7914449
    [No Abstract]   [Full Text] [Related]  

  • 31. Very primitive hemopoietic cells (LTC-IC) are present in Philadelphia negative cytaphereses collected during early recovery after chemotherapy for chronic myeloid leukemia (CML).
    Podestà M; Piaggio G; Frassoni F; Sessarego M; Benvenuto F; Figari O; Pitto A; Vassallo F; Soracco M; Pollicardo N
    Bone Marrow Transplant; 1995 Oct; 16(4):549-55. PubMed ID: 8528171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autologous transplantation for chronic myelogenous leukemia with mafosfamide-treated marrow.
    Rizzoli V; Mangoni L; Almici C; Caramatti C; Dotti GP; Carlo-Stella C
    Stem Cells; 1993 Oct; 11 Suppl 3():25-30. PubMed ID: 8298474
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Autologous stem cell transplantation in chronic myeloid leukemia.
    Olavarria E
    Semin Hematol; 2007 Oct; 44(4):252-8. PubMed ID: 17961724
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparison of chimerism and minimal residual disease between four different allogeneic transplantation methods in patients with chronic myelogenous leukemia in first chronic phase.
    Elmaagacli AH; Runkel K; Steckel N; Opalka B; Trenschel R; Seeber S; Schaefer UW; Beelen DW
    Bone Marrow Transplant; 2001 Apr; 27(8):809-15. PubMed ID: 11477437
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Allogeneic blood stem cell transplantation in chronic myeloid leukaemia-chronic phase following conditioning with busulphan and cyclophosphamide: a follow up report.
    Saikia TK; Parikh PM; Tawde S; Amare-Kadam PS; Rajadhyaksha S; Chhaya S
    Natl Med J India; 2004; 17(2):71-3. PubMed ID: 15141598
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular status of individual CFU-GM colonies derived from chemotherapy-mobilised peripheral blood stem cells in chronic myeloid leukaemia.
    Broughton CM; Sherrington P; Pender NT; Clark RE
    Genes Chromosomes Cancer; 1997 Apr; 18(4):292-8. PubMed ID: 9087569
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Allogeneic peripheral blood progenitor cells for treatment of relapse after bone marrow transplantation.
    Glass B; Majolino I; Dreger P; Scimè R; Santoro A; Vasta S; Suttorp M; Haferlach T; Schmitz N
    Bone Marrow Transplant; 1997 Oct; 20(7):533-41. PubMed ID: 9337054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mobilization of peripheral stem cells with intensive chemotherapy (ICE regimen) and G-CSF in chronic myeloid leukemia.
    Boqué C; Petit J; Sarrá J; Cancelas JA; Muñoz J; Español JI; de la Banda E; Aventin A; Berlanga J; Ferrá C; Amill B; Torrico C; Azqueta C; Llucià M; García J; Grañena A
    Bone Marrow Transplant; 1996 Nov; 18(5):879-84. PubMed ID: 8932840
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cytogenetic analysis and bcr/abl mRNA detection in chronic myeloid leukemia].
    Yao B; Guo M; Pian H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Mar; 20(3):137-9. PubMed ID: 11601240
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Clonal evolution of abnormal Philadelphia chromosome-negative cells after imatinib mesylate therapy in patients with Philadelphia chromosome-positive chronic myelogenous leukemia].
    Jiang Q; Chen SS; Jiang B; Jiang H; Lu Y; Qiu JY; Lu DP
    Zhonghua Xue Ye Xue Za Zhi; 2005 Jan; 26(1):23-6. PubMed ID: 15946504
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.